Reata Pharmaceuticals Inc (NASDAQ:RETA)

39.19
Delayed Data
As of 3:59pm ET
 +0.99 / +2.59%
Today’s Change
18.47
Today|||52-Week Range
95.34
+48.62%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 57.00, with a high estimate of 115.00 and a low estimate of 35.00. The median estimate represents a +45.45% increase from the last price of 39.19.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.19
Sales
$491.4K
Reporting Date
Mar 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.44%
 
 
 
 
 
 
Growthannually -2.74%
 
 
 
 
 
 

Sales

Growthquarterly -8.99%
 
 
 
 
 
 
Growthannually -77.42%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.